The optimal threshold: Baseline serum hepatitis B virus DNA and alanine transaminase levels can predict the 2-Year on-treatment virological response to lamivudine

Author(s):
seyyed yasser saiedi hosseiniseyyed yasser saiedi hosseini1,*
1Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqiayatallah University of Medical Sciences, Tehran, IR Iran

Hepatitis Monthly:Vol. 11, issue 8; 358-363
Published online:May 31, 2011
Article type:Research Article
Received:Dec 21, 2010
Accepted:Jan 25, 2011
How to Cite:saiedi hosseini SY. The optimal threshold: Baseline serum hepatitis B virus DNA and alanine transaminase levels can predict the 2-Year on-treatment virological response to lamivudine. Hepat Mon. 2011;11(8):. doi: https://doi.org/10.5812/kowsar.1735143X.710

Abstract

Fulltext

Full text is available in PDF

Similar Articles

31
May
2011

The optimal threshold: Baseline serum hepatitis B virus DNA and alanine transaminase levels can predict the 2-Year on-treatment virological response to lamivudine

Jie Yan,
Wen Xie,
Qi Wang,
Yue Li,
Xing Feng,
Jun Cheng

Yan J, Xie W, Wang Q, Li Y, Feng X, et al. The optimal threshold: Baseline serum hepatitis B virus DNA and alanine transaminase levels can predict the 2-Year on-treatment virological response to lamivudine. Hepat Mon. 2011;11(5):. doi:

31
May
2011

The optimal threshold: Baseline serum hepatitis B virus DNA and alanine transaminase levels can predict the 2-Year on-treatment virological response to lamivudine

LIU Min,
CAI Haodong

Min L, Haodong C. The optimal threshold: Baseline serum hepatitis B virus DNA and alanine transaminase levels can predict the 2-Year on-treatment virological response to lamivudine. Hepat Mon. 2008;8(1):. doi:

31
May
2011

The optimal threshold: Baseline serum hepatitis B virus DNA and alanine transaminase levels can predict the 2-Year on-treatment virological response to lamivudine

Soo Kim

Kim S. The optimal threshold: Baseline serum hepatitis B virus DNA and alanine transaminase levels can predict the 2-Year on-treatment virological response to lamivudine. Hepat Mon. 2010;10(3):. doi:

31
Dec
2011

Effect and Predictive Elements for 52 Weeks’ Telbivudine Treatment on Naïve HBeAg positive Chronic Hepatitis B

Xiao-Feng Zhu,
Li-Xia Lu,
Ying Wang,
Kong-wen Xu,
Da-jiang Li,
Xia Zhu
,et al.

Zhu X, Lu L, Wang Y, Xu K, Li D, et al. Effect and Predictive Elements for 52 Weeks’ Telbivudine Treatment on Naïve HBeAg positive Chronic Hepatitis B. Hepat Mon. 2011;11(12):e93029. doi: https://doi.org/10.5812/kowsar.1735143X.795

17
Jun
2009

Lamivudine Resistance in Iranian Chronic Hepatitis B Patients

F Fallahian,
SM Alavian,
H Kayvani,
F Alaeddini,
F Zamani

Fallahian F, Alavian S, Kayvani H, Alaeddini F, Zamani F. Lamivudine Resistance in Iranian Chronic Hepatitis B Patients. Shiraz E-Med J. 2009;11(2):20359. doi:


Crossmark
Crossmark
Checking
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles